StockClub

TCRX

TCRXTScan Therapeutics, Inc.$ --
TScan Therapeutics, Inc.

TScan Therapeutics, Inc.

TCRX

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2025FY2025 Q4
Revenue
3M USD
YoY +286.0%
Operating Income
-24M USD
YoY +35.0%
Net Income
-23M USD
YoY +35.8%
EPS
-0.18$
YoY +40.0%

Revenue

$10.3M
FY2024 Q1$566,000
$566,000
Q1
FY2024 Q2$1.1M
$1.1M
Q2
FY2024 Q3$2.2M
$2.2M
Q3
FY2024 Q4$2.8M
$2.8M
Q4
FY2025 Q1$2.2M
$2.2M
Q1
FY2025 Q2$5.2M
$5.2M
Q2
FY2025 Q3$7.8M
$7.8M
Q3
FY2025 Q4$10.3M
$10.3M
Q4
Actual
+$7.5M (+266.7%)

Net Income

$-129.8M
FY2024 Q1$-30.1M
$-30.1M
Q1
FY2024 Q2$-61.8M
$-61.8M
Q2
FY2024 Q3$-91.7M
$-91.7M
Q3
FY2024 Q4$-127.5M
$-127.5M
Q4
FY2025 Q1$-34.1M
$-34.1M
Q1
FY2025 Q2$-71.1M
$-71.1M
Q2
FY2025 Q3$-106.8M
$-106.8M
Q3
FY2025 Q4$-129.8M
$-129.8M
Q4
Actual
$-2.3M (-1.8%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020
Actual:$1.1M
FY2020
$1.1M
FY2021MISS
Actual:$10.1M
Est:$11.3M
FY2021MISS
$10.1M
FY2022MISS
Actual:$13.5M
Est:$13.9M
FY2022MISS
$13.5M
FY2023BEAT
Actual:$21M
Est:$12.2M
FY2023BEAT
$21M
FY2024MISS
Actual:$2.8M
Est:$3.6M
FY2024MISS
$2.8M
FY2025MISS
Actual:$10.3M
Est:$11.2M
FY2025MISS
$10.3M

Analyst Estimates